Ae Wealth Management LLC Adma Biologics, Inc. Transaction History

Ae Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$2.47 - $3.88 $50,350 - $79,093	20,385 New	20,385 $79,000
Q3 2021 Nov 01, 2021	SELL	$1.13 - $1.65 $113,569 - $165,831	-100,504 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$1.51 - $2.07 $761 - $1,043	504 Added 0.5%	100,504 $161,000
Q1 2021 Apr 27, 2021	SELL	$1.67 - $2.95 $17,535 - $30,975	-10,500 Reduced 9.5%	100,000 $176,000
Q4 2020 Feb 01, 2021	BUY	$1.8 - $2.56 $15,300 - $21,760	8,500 Added 8.33%	110,500 $215,000
Q3 2020 Nov 06, 2020	BUY	$2.04 - $3.74 $4,080 - $7,480	2,000 Added 2.0%	102,000 $244,000
Q2 2020 Aug 05, 2020	BUY	$2.42 - $3.29 $242,000 - $329,000	100,000 New	100,000 $293,000

339

182M

1.72M

846K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.05B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.